Inhibitory effect of tyrosine kinase inhibitors on antigen-induced tracheal contraction and histamine release in guinea pigs

International Archives of Allergy and Immunology

Volumn 111, Issue 3, 1996, Pages 291-298

  Iwagoe, Hajime ^a   Kohrogi, Hirotsugu ^a   Fujii, Kazuhiko ^a   Hamamoto, Junji ^a   Hirata, Nahomi ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Genistein; Herbimycin A; Mast cell; Tyrosine kinase

Indexed keywords

GENISTEIN; HERBIMYCIN A; HISTAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HISTAMINE RELEASE; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SMOOTH MUSCLE CONTRACTILITY; TRACHEA;

EID: 0029905997     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237380     Document Type: Article

References (30)

1. 4, increase the release of mucus from human airways in vitro, Am Rev Res-pirDis 1982;126:449-451.
2. 4 and granulocytic infiltration into asthmatic airways, Lancet 1993:341:989-990.
3. Drazcn JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A, Corey EJ: Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro, Proc Natl Acad Sei USA 1980:77:4354-4358.
4. Drazcn JM, Austen KF: Leukotrienes and airway responses, Ain Rev Respir Dis 1987:136: 985-998.
5. Hardy CC, Robinson C, Tattersfield AE, Hol-gate ST: The bronchoconstrictor effect of inhaled prostaglandin D in normal and asthmatic men, N Engl J Med 1984:311:209-213.
6. 4 in humans, Am Rev Respir Dis 1985; 131:368-372.
7. 4 on glycoprotein and lyso/.yme secretion by human bronchial mucosa, Prostaglandins 1983:25:155-169.
8. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of Fcfc'RI or to calcium ionophores, Nature 1989; 339:64-67.
9. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Ilo-warth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-« in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines, Am J Respir Cell Mol Biol 1994:10:471-480.
10. Connelly PA, Farrell CA, Merenda JM, Con-klyn M, Showcll HJ: Tyrosine phoshorylation is an early signaling event common to Fc receptor crosslinking in human neutrophils and rat basophilic leukemia cells (RBL-2H3), Biochem Biophys Res C omtnon 1991; 177:192-201.
11. Bcnhamou M, Gutkind JS, Robbins KC, Siraga-nian RP: Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release, Proc Natl Acad Sci USA 1990:87:5327-5330.
12. Paolini R, Jouvin M-H, Kitict J-P: Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement, Nature 1991:353:855-858.
13. Eiseman E, Bolen JB: Engagement of the high-affmity IgE receptor activates.«:/-protein-related tyrosine kinases, Nature 1992;355:78-80.
14. l>n protein-tyrosine kinase, Proc Natl Acad Sci USA 1994;91:11251-11255.
15. Stephan V, Benhamou M, Gutkind S, Robbins KC, Siraganian RP: FcaRI-induced protein tyrosine phosphorylation of pp72 in rat basophilic leukemia cells (RBL-2H3), J Biol Chern 1992; 267:5434-5441.
16. Kawakami T, Inagaki N, Takei M, Fukamachi H, C'oggeshall KM, Ishizaka K, Ishizaka T: Tyrosine phosphorylation is required for mast cell activation by Fcc RI cross-linking, J Immunol 1992;148:3513-3519.
17. Lavens SE, Pcachell PT, Warner JA: Role of tyrosine kinases IgE-mediated signal transduction in human lung mast cells and basophils, AmJ Respir Cell Mol Biol 1992:7:637-644.
18. Levi-Schaffer F, Austen KF, Caulfield J, Hein A, Gravallese PM, Stevens RL: Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: Morphology and IgE-mediated release of histamine, prostaglandin D, and leu-kotricnes, J Immunol 1987;139:494-500.
19. Hamawy MM, Oliver C, Mergenhagen SE, Si-raganian RP: Adherence of rat basophilic leukemia (RBL-2H3) cells to fibronectin-coatcd surfaces enhances secretion, J Immunol 1992; 149:615-621.
20. Hamawy MM, Mergenhagen SE, Siraganian RP: Adhesion molecules as regulators of mast-cell and basophil function, Immunol Today 1994;15:62-66.
21. Uehara Y, Hori M, Takeuchi T, Umezawa H: Screening of agents which convert 'transformed morphology’ of rous sarcoma virus-infected rat kidney cells to 'normal morphology’: Identification of an active agent as herbimycin and its inhibition of intracellular sre kinase, Jpn J Cancer Res 1985:76:672-675.
22. Uehara Y, Murakami Y, Mizuno S, Kawai S: Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A, Virology 1988:164:294-298.
23. Uehara Y, Fukazawa H: Use and selectivity of herbimycin A as inhibitor of protcin-tyrosine kinases, Methods Enzymol 1991;201:370-379.
24. Miller P, DiOrio C, Moyer M, Schnur RC, Brus-kin A, Cullen W, Moyer JD: Depletion of the crbB-2 gene product pi 85 by benzoquinoid an-samycins, Cancer Res 1994;54:2724-2730.
25. Shore PA, Burkhalter A, Cohn VI I: A method for thr fluoromctric assay of histamine in tissues, J Pharmacol ExpTher 1959:127:182-186.
26. 1’ signals in rat basophilic leukemia (RBL-2H3) cells, Biochim Biophys Acta 1994;1221:37-46.
27. Hagmann W: Ceil proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukemia and a mastocytoma cell line, Biochem J 1994;299:467-472.
28. Akiyama T, Ogawara H: Use and selectivity of genistein as inhibitor of protein-tyrosinc kinases, Methods Enzymol 1991;201:362-370.
29. Levitzki A, Gazit A: Tyrosine kinase inhibition: An approach to drug development, Science 1995: 567:1782-1788.
30. Uckua FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chclstrom LM, Burckhardt A, Bolen J, Myers DE: Biotherapy of B-cell precursor leukemia by targeting genistein to CDI9-associated tyrosine kinases, Science 1995:267:886-891.